ARTICLE | Clinical News
Tekturna regulatory update
April 23, 2012 7:00 AM UTC
Novartis updated the label of hypertension drug Tekturna aliskiren in the U.S. to include a contraindication against the use of aliskiren-based products with angiotensin-converting enzyme (ACE) inhib...